The DCT OS Report: More than 95% of biopharma executives say we're not going back to a site-based-only development model. Learn more

Webinar: What's Next in Clinical Trials

Science 37®, the Operating System™ that powers agile clinical trials, is releasing important study findings and sharing new data on the evolution of clinical trials.

ACT-SURVEY-WEBINAR-POST-EVENT-HEADER-(2).jpg
What does the future of clinical trials hold? Will sponsors choose decentralized over traditional trials, or will agile clinical trials become the norm? How is technology changing to support an ever-evolving research landscape?

During this 30-minute presentation, our Chief Strategy Officer, Drew Bustos and our Senior Director of Leadership, James Chase, will cover; the therapeutic areas and study phases will see the biggest increases in decentralized activity; the key steps CROs and sponsors should take to empower the clinical trial of the future and; what the clinical trial of the future will look like and why it’s less likely to be fully traditional or fully decentralized.

While you view the webinar, click through here to access the report, and a slide deck presentation on the report, all in one place.